Skip to search formSkip to main contentSkip to account menu

Bupivacaine liposome Injection [Exparel]

National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

20 ML Bupivacaine liposome 13.3 MG/ML Injection [Exparel]
ExparelInjection

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Perineural dexamethasone attenuates liposomal bupivacaine-induced delayed neural inflammation in mice in vivo.
Review
2020
Review
2020
A short survey can help to decrease post-operative opioid prescribing
Deaths related to drug overdose are increasing every year. Of the more than 60,000 overdose deaths annually, two-thirds involve… 
2019
2019
MP38-12 LIPOSOMAL BUPIVACAINE (EXPAREL®) ADMINISTRATION IN OPEN RADICAL CYSTECTOMY IS ASSOCIATED WITH DECREASED POST-OPERATIVE PAIN, LENGTH OF STAY, AND OPIOID USE
INTRODUCTION AND OBJECTIVES: Liposomal bupivacaine (Exparel®, LB) is a slow-release, depofoam formulation indicated for… 
Review
2019
Review
2019
Reduction of opioid use after implementation of enhanced recovery after bariatric surgery (ERABS)
Background Enhanced recovery after surgery (ERAS) protocols have been extensively proven in lower gastrointestinal surgery to… 
2019
2019
Neurological and histological outcomes after subarachnoid injection of a liposomal bupivacaine suspension in pigs: a pilot study
Review
2017
Review
2017
The effect of local/topical analgesics on incisional pain in a pig model
Interest in the development of new topical/local drug administration for blocking pain at peripheral sites, with maximum drug… 
2016
2016
Analgesic Efficacy and Safety of Exparel® (bupivacaine liposome injectable suspension) in Subjects Undergoing Third Molar Surgery: Preliminary Results of a Randomized Controlled Study
Highly Cited
2014
Highly Cited
2014
Multivesicular liposomal bupivacaine at the sciatic nerve.
Highly Cited
2012
Highly Cited
2012
Extended pain relief trial utilizing infiltration of Exparel®, a long-acting multivesicular liposome formulation of bupivacaine: a Phase IV health economic trial in adult patients undergoing open…
Background The majority of surgical patients experience significant levels of pain after a procedure. While opioid analgesics… 
Highly Cited
2012
Highly Cited
2012
The Safety of EXPAREL ® (Bupivacaine Liposome Injectable Suspension) Administered by Peripheral Nerve Block in Rabbits and Dogs
A sustained-release DepoFoam injection formulation of bupivacaine (EXPAREL, 15 mg/mL) is currently being investigated for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)